Thrombolysis for evolving myocardial infarction. Health and Public Policy Committee, American College of Physicians.
D000800:Angioplasty, Balloon; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000628:therapy; D003331:Coronary Vessels; D003365:Costs and Cost Analysis; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D007263:Infusions, Parenteral; D007269:Injections, Intra-Arterial; D009203:Myocardial Infarction / Q000188:drug therapy*; D010960:Plasminogen Activators / Q000627:therapeutic use; D012008:Recurrence; D012306:Risk; D013300:Streptokinase / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D013300:Streptokinase; D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator